Summary.-Experiments were undertaken to test a new hypothesis for the mechanism underlying the Revesz effect. The hypothesis proposes that lethally irradiated (LI) tumour cells enhance the take probability of a small number of transplanted viable (V) tumour cells mixed with them by exerting a thromboplastic effect at the site of injection; local fibrin formation prevents emigration of V cells from the site or secures their survival there. The evidence presented to support this hypothesis is as follows: in the case of 3 isogeneically transplanted tumours, admixed particulate brain extract simulated the effect of LI cells in increasing the take probability of V cells; brain extract simulated the effect of LI cells in greatly delaying the disappearance of 125IUdR-labelled viable carcinoma cells from the injection site; V cells acquired a raised take probability by their incorporation in fibrin clots; it was confirmed that admixed erythrocytes increased the take probability of V cells; using a newly devised microscopical test for detection of the thromboplastic activity of individual cells, it was found that cell death was almost always required for the display of such activity; lymphocytes and bone marrow cells, ineffective in enhancing the take of V cells, were almost totally devoid of thromboplastic activity. Possible explanations are given for failure of a fibrinogen depleting agent, ancrod (Arvin) to inhibit the Revesz effect when administered to recipients. It is concluded that the evidence strongly supports the hypothesis presented whilst seriously weakening the long-standing theories that admixed LI cells act by provision of nutrients or by local quenching of postulated immune reactivity.
Summary.-Experiments were undertaken to test a new hypothesis for the mechanism underlying the Revesz effect. The hypothesis proposes that lethally irradiated (LI) tumour cells enhance the take probability of a small number of transplanted viable (V) tumour cells mixed with them by exerting a thromboplastic effect at the site of injection; local fibrin formation prevents emigration of V cells from the site or secures their survival there. The evidence presented to support this hypothesis is as follows: in the case of 3 isogeneically transplanted tumours, admixed particulate brain extract simulated the effect of LI cells in increasing the take probability of V cells; brain extract simulated the effect of LI cells in greatly delaying the disappearance of 125IUdR-labelled viable carcinoma cells from the injection site; V cells acquired a raised take probability by their incorporation in fibrin clots; it was confirmed that admixed erythrocytes increased the take probability of V cells; using a newly devised microscopical test for detection of the thromboplastic activity of individual cells, it was found that cell death was almost always required for the display of such activity; lymphocytes and bone marrow cells, ineffective in enhancing the take of V cells, were almost totally devoid of thromboplastic activity. Possible explanations are given for failure of a fibrinogen depleting agent, ancrod (Arvin) to inhibit the Revesz effect when administered to recipients. It is concluded that the evidence strongly supports the hypothesis presented whilst seriously weakening the long-standing theories that admixed LI cells act by provision of nutrients or by local quenching of postulated immune reactivity. RE'vtsz (1956) first described the stimulation of the growth of transplanted murine tumours which results when a preponderance of lethally irradiated (LI) tumour cells are added to an inoculum of viable (V) cells. It is remarkable that further studies of this effect by Revesz and by others during the subsequent 17 years have not led to an understanding of the mechanism of the effect.
In a recent report from this laboratory (Hewitt, Blake and Porter, 1973) the results offully quantitative transplantation assays were described using a carcinoma (" N.T. It has long been known that a variety of factors influence the ability of circulating tumour cells to implant and give rise to " metastatic " growth, whether the cells are injected intravenously or have been disseminated naturally from a primary implanted tumour (Wood, Holyoke and Yardley, 1961) . Prominent among such factors have been blood coagulability, many investigators having found that anticoagulants reduce the tendency of disseminated cells to " seed " in the tissues. It occurred to us to explore possible analogies between the factors governing metastasis and those governing the ability of injected viable tumour cells to give rise to progressive tumours. The question arose whether LI cells enhance the conditions for growth of viable tumour cells injected subcutaneously by exerting a local thromboplastic influence. This paper reports a series of experiments by which an attempt was made to answer this question.
MATERIALS AND METHODS
Mice and tumours.-Mice of 2 inbred strains were used: CBA/Ht and WHT/Ht. The tumours used were: CBA Carcinoma " N.T.", CBA Sarcoma "' F ", CBA Leukaemia IV, WHT Ascites Tumour I and WHT Squamous Carcinoma " G ". All these tumours arose spontaneously and have been maintained by serial transplantation in the mouse substrain of origin. References to their use in previous experiments have been given by Hewitt et at. (1973) .
Transplantation assays of tumour cells.-The methods for preparing single-cell suspensions from solid tumours have been described previously (Hewitt, 1966) . The values of TD50 and their confidence limits were calculated from the data of assays by statistical methods described recently (Porter, Hewitt and Blake, 1973) . Figure 1 shows, for CBA Carcinoma " N.T.", the dependence of percentage tumour incidence on the log number of viable cells injected per site. The right hand curve is for viable cells injected alone, and the left hand curve is for viable cells injected in mixture with 3.5 x 104 LI cells per inoculum.
Comparison of these two curves shows that an inoculum of 200-300 viable cells (2.3-2-5 log) gives a take incidence of under 10% without LI cells, and an incidence approaching 100% with LI cells. The finding provides the basis of a number of our experiments using this tumour, in which the enhancing effect of an additive has been demonstrated by its ability to give a relatively high incidence of tumours from 200 to 300 viable cells.
Preparation of LI tumour cells.-Cell suspensions prepared as for viable cells were exposed to 7-8 krad while enclosed in a glass vial standing in an ice bath. All LI suspensions were tested for inactivation by injection into appropriate mice which were observed for at least 5 months; no suspensions so tested have given rise to tumours.
Preparation of brain extract.-Several brains were excised from normal mice and homogenized by grinding with sand. Phosphate buffered saline was added to give a final brain tissue concentration of 250 mg/ml. The diluted homogenate was lightly centrifuged to remove connective tissue fragments and sand and the opaque supernatant fluid was used in the experiments. In one experiment the supernatant was further centri-fuged (2100 g for 10 min) to provide an opalescent particle-free supernatant fluid.
Preparation of clots as vehicles for tumour cell transplantation.-Two techniques were used: Preformed fibrin clots were made by suspending viable tumour cells to the required density in a 10% solution of pure human fibrinogen (Koch-Light Laboratories) in saline; aliquots of 0-1 ml were clotted with thrombin in vitro and the discrete clots were implanted subcutaneously through a small incision. In situ clots were produced as follows: fresh mouse blood was collected into one-tenth its volume of 3X13% sodium citrate containing 10% E-amino caproic acid; platelet-poor plasma was separated by centrifugation and viable tumour cells were added to the required density; aliquots of 0-5 ml of the mixed suspension (to provide four 0-1 ml inocula per mouse) were recalcified immediately before injection; the 4 injections were completed within the 40-60 sec clotting time so that the inocula clotted in vivo almost immediately after injection; this was verified by the formation of palpable nodules at the injection sites.
Experiments u?sing cells labelled with 5-125iodo-21-deoxyuridine (125IUdR).-The thymidine analogue 125IUdR is incorporated into the DNA of proliferating cells and is released only after cell death (Commerford, 1965) . It is very little re-utilized (Dethlefson, 1971 ) and therefore provides a suitable label for studying the fate of injected tumour cells.
The method used for in vitro labelling of CBA " N.T." cells, based on that of Fidler (1970) , was as follows: a tumour cell suspension was prepared as described above and approximately 4 x 105 viable cells were plated into each of twelve 5 cm plastic petri dishes with 4 ml of Eagle's MEM containing 15% foetal calf serum and '25JUdR 0-4 ,uCi/ ml (specific activity 1-6 mCi/mg). The cultures were incubated at 37°C in an atmosphere of air containing 5% C02. In some experiments, the '25IUdR was not added until the cells had been in culture overnight; in all cases, however, the cultures were harvested after an exposure of 24 hours to the labelled DNA precursor. After pouring off the medium, the cells were removed with phosphate buffered saline containing trypsin 0-2%, pancreatin 0-05%, and sodium citrate 0-3%; they were then washed repeatedly in phosphate buffered saline at pH 7-3 until the activity of the supernate per 0-1 ml was indistinguishable from background. The cells were finally re-suspended in Tyrode solution containing 5% mouse serum and were sedimented under gravity in narrow glass tubes to remove clumps. Counts of " viable " and "dead" cells were made on phasecontrast appearances. No evidence of radiotoxicity was observed with this technique, as measured by in vivo assays of cultured, labelled cells.
Labelling indices were determined by fixing a sample of the cells in methanol/ glacial acetic acid (3 : 1) and exposing smears of these fixed cells to Ilford K5 nuclear liquid emulsion for 6 days. After developing, the autoradiographs were counterstained with aceto-orcein. The percentage of labelled cells so determined was at least 90% in these experiments.
All measurements of radioactivity were made with a LKB Wallac 80,000 automatic gamma sample counter; 5000 counts were accumulated for each sample. The level of activity attained was approximately 1 ct/sec/ 100 cells.
Recognition of thromboplastic effect of individual cells.-The following test was devised to permit comparison of thromboplastic activity between cells of different origins and morphology as seen by phasecontrast microscopy.
Pooled samples of human blood containing sodium EDTA as anticoagulant were centrifuged and the plasma was recovered. To 2 ml of EDTA treated plasma was added 5 i.u. of heparin followed by 2 mg CaCl2, each in 0-1 ml of physiological saline. Suspensions of tumour or normal cells to be examined were well washed in Tyrode solution and diluted to contain approximately 3000 cells/mm3. Equal volumes of cell suspension and prepared human plasma were mixed and the mixture was used to fill a Turck haemacytometer. The filled haemacytometer was incubated at 37°C for 20 min in a humidified chamber before examination by phase-contrast microscopy. A proportion of the cells in many such preparations display a very striking appearance, being surrounded by a corona of needle-like fibres extending radially from the cell margin; the length of the fibres extends gradually until they are several cell diameters in length. Further incubation is associated with increasing density of the fibres round affected cells, while initially unaffected cells usually remain quite free from fibres. Thus, differences between affected and unaffected cells appear to represent qualitative, rather than quantitative, differences of cellular thromboplastic capacity. Strong evidence that the fibres are of fibrin is provided by our observation that fibres do not form in serum, that they can be seen to disappear when trypsin is allowed to diffuse into the chamber, and that they form in great density around deposits of dried brain extract and around megakaryocytes. It is concluded that formation of the fibres is associated with coagulative factors accessible at the cell surface or secreted by the cells. For convenience, affected cells are referred to as C9 star" cells. The proportion of " star" cells in a suspension is determined by counting in relation to the density of living and dead cells present in the suspension.
Treatment of mice with ancrod (Arvin). Arvin (Twyford Laboratories Ltd) is a purified enzyme fraction of Malayan pit viper venom. Injected into mammals, this has a thrombin-like action: fibrinogen is converted to fibrin which is removed by fibrinolysis, leaving the blood in a temporarily incoagulable condition from severe hypofibrinogenaemia. In the experiments reported by Hagmar (1972) , repeated intraperitoneal injections of the drug into mice were complicated and restricted by the occurrence of intraperitoneal haemorrhage, presumably from damage to blood vessels by the injecting needle. We have completely avoided this complication by giving the injections in the mid-line through the avascular linea alba.
Our schedule of treatment of CBA mice, based on Hagmar's detailed observations, was as follows: 3 doses of 50 u/kg body weight at 4-hour intervals, followed after 8 hours by 8-hourly injections of 100 u/kg; treatment was maintained for 4 days. Samples of tail vein blood taken from treated mice immediately before the administration of scheduled doses were taken into capillary tubes and incubated at 37°C; coagulation of blood was sought at intervals up to 16 hours by inspection of a capillary, and of its contents after their expulsion; no evidence of coagulation was seen in any specimen taken during the course of treatment. In view of Hagmar's (1972) In addition, single point assays of CBA " N.T." have been done to compare the efficacy of different preparations of brain extract: BE (1) standard extract prepared as described previously in this paper; BE (2) as above, except that no sand was used in grinding the brains; minimal sedimentation was used to remove any larger fragments of connective tissue but essentially this was a " whole " brain extract. BE (3) the standard extract was centrifuged at 2100 g for 10 min to remove virtually all particulate material, leaving a " soluble " extract.
By using 200 V cells in these assays, excellent discrimination was obtained between effective and non-effective preparations (see Fig. 1 ). Results (tumour takes/sites injected) were as follows: BE (1), 23/24; BE (2), 24/24; BE (3), 1/28; controls (no brain extract), 4/28.
Thus, it is clear that the " soluble" extract is ineffective, whereas there is no difference between the standard and " whole " preparations. This difference, we believe, is due to the requirement of a sustained thromboplastic influence at the In these experiments it was necessary to use more than our usual 200-300 V cells in order to obtain measurable levels of activity per inoculum without radiotoxicity. The two experiments described here involved inocula of 800-1000 V cells, which, by reference to Fig. 1 that the cells represented by this residual activity are those injected cells which actually contribute to tumour development, and it is of interest to compare the measured activity levels with the tumour take incidences which resulted from the same inocula as set out in Table III . Conversion of residual activity measurements to equivalent cells can be only approximate because of the contribution to initial activity of labelled non-viable cells and of non-DNA-bound label. Results of other experiments not reported here suggest that the rapid decline in activity over the first 12 hours after injection is due partly to these elements. Nonetheless, it is readily apparent that the effective " take unit " consists of only a very few V cells, and that at 120 hours the relative number of injected cells retained locally is greatly augmented by their admixture with LI cells; indeed, the " stimulation " of tumour growth can be interpreted in these terms. In a similar experiment, the effect of brain extract in place of LI cells was observed. Figure 2 indicates graphically the qualitative similarity of the data, although with brain extract the final ratio of activities was 1: 12 compared with 1: 30 for LI cells. This is in accord with the slightly smaller effect of brain extract in reducing the TD50, as described previously in this paper.
Evidence of retardation of cell emigration by brain extract
When cells of CBA Leukaemia IV are injected subcutaneously, the recipient inevitably develops generalized leukaemia. In most cases no lesion develops at the injection site, though occasionally an ill-defined flattened infiltration may be noted.
If emigration of the leukaemia cells were retarded, two effects should be noted: local tumour growth and prolonged survival. In the present experiment, 104 leukaemia cells were injected with or without brain extract into groups of 6-8 mice. After 17 days, when the Table IV . The increase of local tumour incidence with brain extract is not statistically significant, but the reduction in spleen weights is highly significant (P < 0.005). Brain extract injected remotely had no effect on evolution of the disease. 
Transplantation of tumour cells in fibrin clots
The demonstration that brain extract greatly reduced the number of At cells required for transplantation in at least 3 different systems suggested that the formation of a fibrin mesh at the injection site might be an important factor in the establishment of a successful graft.
In the first experimental design, we observed the result of implanting 300 V cells of CBA " N.T." in preformed fibrin clots. Progressive tumours developed in all recipients (6/6); the probability of this occurring with 300 V cells injected alone is less than 1: 1000 (see Fig. 1 ).
To exclude the possibility that surgical trauma associated with surgical implantation influenced the take probability, we assayed 210 V cells of CBA " N.T." in in situ clots by the technique described in the previous section. The resulting tumour incidence was 20/20.
Thus, it is apparent that the number of cells required for tumour take was reduced dramatically by incorporation of cells in clots by both techniques.
The mean latent period before appearance of tumours from preformed fibrin clots (40 days) was rather long (Hewitt et al., 1973) , possibly reflecting the increased diffusion distances required for provision of cell nutrients. Successful tumour takes with relativelv small numbers of V cells under conditions which increase the diffusion distances for nutritional provision argue strongly against the assertion that nutritional deficiences limit the take of small numbers of cells injected directly into the subcutaneous tissue without additives. The results confirm the finding of Yatvin et al. (1973) , using a different tumour and end point. It is relevant to note here that erythrocyte lysate has thromboplastic (Quick, Georgatsos and Hussey, 1954) Our observation that cell death almost invariably precedes the exhibition of pericellular thromboplasia suggests that admixed cells which are able to promote the initiation of tumours from small inocula of viable cells may actually require preliminary lethal irradiation as a condition for expression of their thromboplastic activity.
Failure of ancrod to inhibit the effect of LI cells
If the enhancement of tumour takes by admixed LI cells is associated with a thromboplastic effect of the latter, their influence should be reduced or abolished using recipients having a defect of blood coagulation which precluded fibrin formation.
A mixture of 200 V and 225,000 LI cells of CBA " N.T." was injected subcutaneously in 4 sites in each of 10 CBA mice in which a severe blood coagulation defect ha(l been in(luced by repeated injections of ancrod according to the schedule of treatment described in the previous section. Ten control mice received the same inocula of tumour cells but were given injections of saline at the same times as the test mice received ancrod. Although the blood of the ancrod treated mice was shown to be incoagulable from some hours before until 4 days after injection of tumour cells, the final incidences of tumours and the mean latent periods before their appearance (1 6-5 days) were not significantly different between the two groups: 40/40 sites developed tumours in the treated group, and 38/40 in the control group. The results of this experiment do not support the hypothesis it was designed to test. On the other hand, it is conceivable that blood incoagulability was not maintained for a sufficiently long period. Further consideration of this experiment appears in the Discussion.
DISCUSSION
An association between the growth or metastasizing potential of tumours and the formation of fibrin has been the subject of many publications during the last two decades. O'Meara (1958) suggested that growth of a tumour is conditional upon the prior formation of a fibrin lattice in the adjacent tumour bed and that this formation is maintained by the tumour itself. Many investigators have studied the effect of perturbations of the blood coagulation system of animals on the metastasizing potential of tumour cells embolized from tumours or injected intravenously. It is not our purpose to review the extensive reports on this topic, which are by no means unanimous in respect of their findings and interpretations. However, it may be said that the balance of evidence favours the view that tumour growth or the seeding of embolized cells is enhanced by conditions which encourage the formation or stability of fibrin and is decreased by treatments which inhibit coagulationi or encourage fibrinolysis (e.g. Ketcham et al., 1971; Cliffton and Agostino, 1964) .
Consideration of the above suggested to us that the promotion of tumour take incidence by admixed LI tumour cells might be associated with a thromboplastic effect of such cells. Strong evidence in favour of this interpretation was provided by our demonstration that brain extract, a rich source of thromboplastin, simulated the effect of LI cells in all of the 3 tumour systems examined. The similar but less powerful effect of admixed erythrocytes, first demonstrated by Yatvin et al. (1973) , provided further supportive evidence, in that Quick et al. (1954) have shown that erythrocyte lysate is thromboplastic. The fact that incorporation of viable cells in pure fibrin clots before implantation enhanced their capacity to give rise to tumours is very cogent evidence that stimulation of local fibrin deposition may be implicated in the Revesz effect.
In a previous publication from this laboratory (Hewitt et al., 1973) evidence was presented to show that the effect of admixed LI cells was to increase the number of injected clonogenic cells contributing to initiation of a tumour. The result of such increase would be to raise the take incidence from a given number of viable cells and to reduce both the latent period before appearance of tumours and the time taken for tumours to reach a specified, or lethal, size. A possible interpretation is that many of the viable cells injected without additive are lost from the site of injection, the effect of the additive being to retain them there. Steel, 1968) . It can be conjectured that progressive growth of a solid tumour, as well as its initiation, may sometimes be conditional upon influences which these dead cells exert.
In view of the large measure of support for our hypothesis, our failure to demonstrate inhibition of the Revesz effect by treatment of injected mice with the defibrinating agent, ancrod, deserves further consideration. As judged by the rate of loss of 125IUdR-labelled cells, ancrod treatment was continued sufficiently long after injection of tumour cells; however, it is possible that treatment was not started sufficiently long before injection of tumour cells to deplete fibrinogen in the interstitial tissue. Alternatively, fibrin deposited by the action of ancrod itself may have persisted long enough to provide a suitable microenvironment for tumour initiation. We propose to undertake further studies with ancrod.
Our finding that pure fibrin clots and erythrocytes, both devoid of nuclear material, have some capacity to simulate the effect of LI cells is discouraging to the theory that LI cells act by providing essential nutrients not otherwise available to the injected tumour cells. Evidence and arguments against a rival theorythat LI cells act by inducing local immunosuppression-have been presented elsewhere (Hewitt et al., 1973) .
We have considered the possibility that the thromboplastic influence we have consistently found for effective additives has some equivalence with the tumour angiogenesis factor described by Folkman et at. (1971) . Whilst the two factors could conceivably be elaborated by a single additive, their distinction is suggested by our observation that brain extract, a potent simulator of LI tumour cells, had no angiogenic effect when tested by the implantation of millipore chambers containing it.
Our present understanding of the mechanism of the Revesz effect can be summarized as follows: it is suggested that, in the case of tumours having a relatively high TD50 by the subcutaneous route, a large proportion of viable cells injected alone either die on site or after their emigration from the site; the addition of LI cells (and of some other additives) to the inocula ensures a sustained thromboplastic influence at the site with the production of a fibrin lattice which either prevents emigration of viable cells or secures their survival at the site. The fibrin lattice may also provide the conditions required for stromification of the growing tumour, as suggested by O'Meara (1958) . We suggest that tissue cell additives do not release an effective level ofthromboplastic activity unless and until they undergo degenerative changes.
The superiority of some LI tumour cell suspensions in exerting the Revesz effect may be attributable to a high content of thromboplastic agents in tumour cells; it may also be partly dependent on the high proportion of cycling cells in such suspensions, for an attempt at mitosis is usually required for the expression of radiation damage by cell death.
The TD50 for viable tumour cells is commonly much reduced when the mice used for transplantation assay have received sublethal whole-body irradiation (WBI). An almost unchallenged interpretation of this finding is that WBI suppresses an effective level of immunity in the recipients. However, since the phenomenon is commonly observed using isogeneic tumour host systems in which no other evidence of transplantation immunity can be demonstrated, we have been encouraged to question whether suppression of immunity is implicated in this effect. It is known that sublethal WBI, in rats at least, stimulates a substantial increase in the rate of synthesis of fibrinogen (John and Miller, 1968) with peaks at 3 hours and 4 days after exposure (Nadkarni and Samuel, 1973) . Our present investigations are directed to an examination of possible common factors linking the mechanisms whereby locally injected LI cells, and WBI of the recipients, reduce the TD50 values for viable cells of solid tumours transplanted within isogeneic tumour-host systems.
The question arises whether the Revesz effect, exerted by the mechanism we have suggested, has implications for the course or response to therapy of clinical cancer. We have already referred to a possible analogy between the conditions influencing seeding of metastases from embolized cells and those affecting the initiation of tumours from small numbers of transplanted viable tumour cells. A further consideration is whether the stimulation of growth of surviving cells which has been demonstrated in irradiated tumours undergoing regression (van Peperzeel, 1972 ) is partly dependent on a local release of thromboplastic substances from non-surviving cells during expression of their radiation damage. Finally, we suggest a possible relevance of our studies to the uncommon but well-documented phenomenon in which clinical recurrences or metastases coincide geometrically with an irradiated area. It seems to us that release of tissue thromboplastins associated with radiation damage could underlie this phenomenon, in the same way as such release is invoked to explain the predisposition of sites of accidental or surgical trauma to tumour recurrence or metastasis. This understanding appears preferable to that provided by the widely current and unsupported hypothesis that irradiation suppresses locally a form of immunity not independently demonstrable. The interpretation we have suggested allows us to reconcile the apparent contradiction between experiments which demonstrate increased tumour " takes " in acutely irradiated lung (van den Brenk et al., 1973) and those which have shown a reduced rate of growth of tumours transplanted to pre-irradiated sites (Sten- 
